Literature DB >> 17597875

Artificial life and living systems: Insight into artificial life and its implications in life science research.

Sarvothaman Guruprasad1, Kanagaraj Sekar.   

Abstract

Advanced technology has made it possible to build machines and systems like robots, which are capable of making intelligent decisions. Robots capable of self-replication and perform human functions are also available. The current challenge is to design evolutionary systems with high complexity comparable to that of biological networks. This is proposed to be achieved by ALife (Artificial Life). Here, we describe the promises provided by ALife for life sciences.

Entities:  

Year:  2006        PMID: 17597875      PMCID: PMC1891673          DOI: 10.6026/97320630001139

Source DB:  PubMed          Journal:  Bioinformation        ISSN: 0973-2063


Cellular automatons and biology

Jon Von Neumann, arguably, laid the foundations for the field of ALife. His UC (Universal Constructor) demonstrated evolutionary growth of complexity in a machine, akin to biological evolution. [1] The UC, a machine, is isolated from its own definition, analogous to the genotype and phenotype of a biological organism. The UC is also capable of self-replication coupled with growth in complexity. Other such and more advanced systems have also been created, some based on the UC and some not. Examples of these are the Game of Life, Tierra etc., which provide a way of studying artificial self-replication and natural selection in their own environments. [1] Appropriate mathematical conditions are to be imposed in such computer systems to eliminate trivial self-reproduction or “un-inheritable mutations”, to be useful from a practical biological viewpoint. Hence, ALife is a powerful tool for studying, simulating, and recreating biological systems and processes. The Von Neumann UC, a cellular automaton, has been a motivation for creating complex systems which are similar to biological systems. Its capability for universal computation also provides a basis for developing intelligent and complex systems which may find direct application in synthetic biology. The challenge, however, is in formalizing the notion of adaptive complexity in biology which is a grand challenge for evolutionary biology and ALife. [1]

Scope of artificial life

ALife adopts a bottom-up methodology in designing systems or simulations that are life-like, with characteristics such as growth, death, evolution etc. That is, starting from the simplest elements and aggregating them to form complex systems. Artificial Intelligence, on the other hand looks to solve specific problems using human-like behavior, but not to build complex systems from scratch. Thus, these two ‘artificial’ fields are fundamentally different, each having its own professed goals. The goal of ALife is to study ‘intelligence’ or ‘logic’ underlying natural processes and using them in recreating alternative media like hardware or synthetic organs for humans. [2] With effective computation, one may be able to integrate the simulations of key components of biological networks to the level of macromolecular kinetics, which would provide further insight into biological systems. [3] ALife not only helps simulate and understand natural processes but ALife is also aimed at building systems in the real world based on these processes. [2] ALife is already finding application in building physical devices such as evolvable hardware and robots, and in network and cyber security. The motivation has been from biological systems like the immune systems in nature. [4] More such robust systems can be designed by studying the natural and highly adaptive processes.

Artificial life and synthetic biology

Synthetic biology is similar to the science of genetically engineered microorganisms. [5] In this respect, ALife and synthetic biology are foundationally similar. ALife is aimed at abstracting away the process of life from the natural medium and provides a novel alternative in redesigning biological systems using bottom-up methodology. Comparisons can, thus, be made between observed and predicted behavior aiding in the study of biological systems. The self replication of cellular automatons, with their similarity to biological systems, may prove to be a handy tool in designing cells and systems. This process will typically involve integrating various modeled biological components and data to form biological systems. [6] Living systems are composed of macromolecules (DNA, RNA, proteins, carbohydrates, lipds, water and mineral salts). However, molecules performing similar functions can be designed. Synthetic biologists propose to design such molecules and systems for simulating natural processes in living cells. [5] Building such alternative life needs effective simulation and modeling tools for study and design. The greatest challenge is the creation of standards for such designed components to allow interchangeability. An example is the Registry of Standard Biological Parts, which has been set up by the MIT team. [7] An existing, yet an exemplary standard, is the PoPS (Polymerase per Second) which is the flow of RNA polymerase over DNA and is independent of the DNA sequence. The challenge thus, is to bring an engineering approach to ALife towards the designing of biological systems. Applied research on cost effective drug discovery systems through alternative molecules, energy generation from microorganisms and bioremediation uses fundamental evolutionary concepts in ALife. Nonetheless, a concerted effort in formalizing interdisciplinary ALife and Biology research to achieve the common goal of studying and recreating life-like and living systems is lacking. Designing living systems is non-trivial and future developments in ALife finds application in medicine and biotechnology.

Conclusion

Artificial Life is an interdisciplinary science involving psychology, cognitive science, mathematics, biology and complex computations. Development of models in synthetic biology with appropriate validation finds enormous application in biomedicine. In its current status, standardization of synthesized biological components and formalization of methodologies remains as a challenge.
  3 in total

1.  Fundamental issues in systems biology.

Authors:  Maureen A O'Malley; John Dupré
Journal:  Bioessays       Date:  2005-12       Impact factor: 4.345

2.  John von Neumann and the evolutionary growth of complexity: looking backward, looking forward...

Authors:  B McMullin
Journal:  Artif Life       Date:  2000       Impact factor: 0.667

Review 3.  Synthetic biology.

Authors:  Steven A Benner; A Michael Sismour
Journal:  Nat Rev Genet       Date:  2005-07       Impact factor: 53.242

  3 in total
  1 in total

1.  It's life, but just as we know it.

Authors:  Mark Greener
Journal:  EMBO Rep       Date:  2008-11       Impact factor: 8.807

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.